2023 Q3 Form 10-Q Financial Statement

#000155837023014241 Filed on August 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $43.57M $25.48M $18.05M
YoY Change 13.43% -37.46%
Cost Of Revenue $31.57M $24.65M $20.08M
YoY Change -1.05% -32.26%
Gross Profit $12.00M $830.0K -$2.030M
YoY Change 84.42% -80.92%
Gross Profit Margin 27.55% 3.26% -11.25%
Selling, General & Admin $7.510M $7.650M $5.255M
YoY Change 2.81% -488.32%
% of Gross Profit 62.56% 921.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.124M $1.090M $1.349M
YoY Change -2.26% -54.77%
% of Gross Profit 9.36% 131.33%
Operating Expenses $8.911M $8.990M $29.27M
YoY Change 5.88% -58.86%
Operating Profit $3.093M -$8.160M -$31.30M
YoY Change -262.19% -53.37%
Interest Expense -$84.37M -$80.74M -$13.62M
YoY Change -533.22% 4823.17%
% of Operating Profit -2727.74%
Other Income/Expense, Net $181.0K $315.0K
YoY Change 53.39% 668.29%
Pretax Income -$81.76M -$89.93M -$32.46M
YoY Change -565.38% 330.7%
Income Tax
% Of Pretax Income
Net Earnings -$81.81M -$89.96M -$32.45M
YoY Change -567.21% 330.64%
Net Earnings / Revenue -187.77% -353.07% -179.76%
Basic Earnings Per Share -$6.14 -$6.75
Diluted Earnings Per Share -$6.14 -$6.75 -$2.44
COMMON SHARES
Basic Shares Outstanding 13.32M 13.32M
Diluted Shares Outstanding 13.32M 13.32M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $45.56M $54.90M
YoY Change
Cash & Equivalents $45.56M $54.94M $4.227M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $45.56M $54.90M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $276.1M $293.8M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $241.0M $321.2M $587.1M
YoY Change
Other Assets $5.653M $2.900M
YoY Change
Total Long-Term Assets $558.7M $647.5M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $45.56M $54.90M
Total Long-Term Assets $558.7M $647.5M
Total Assets $604.3M $702.4M $1.005B
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $6.364M $7.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.364M $7.200M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $212.8M $227.4M
YoY Change
Other Long-Term Liabilities $36.30M $37.10M
YoY Change
Total Long-Term Liabilities $249.1M $264.5M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.364M $7.200M
Total Long-Term Liabilities $249.1M $264.5M
Total Liabilities $255.5M $271.7M $33.10M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$262.6M -$180.8M
YoY Change
Common Stock $13.00K $13.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $344.9M $426.9M
YoY Change
Total Liabilities & Shareholders Equity $604.3M $702.4M $1.005B
YoY Change

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$81.81M -$89.96M -$32.45M
YoY Change -567.21% 330.64%
Depreciation, Depletion And Amortization $1.124M $1.090M $1.349M
YoY Change -2.26% -54.77%
Cash From Operating Activities -$8.319M -$4.110M -$9.140M
YoY Change -931.9% -78.62%
INVESTING ACTIVITIES
Capital Expenditures $686.0K $5.220M $5.950M
YoY Change -88.74% -50.0%
Acquisitions
YoY Change
Other Investing Activities $17.69M $17.32M $134.2M
YoY Change -67.57% -75.18%
Cash From Investing Activities $17.00M $12.10M $128.3M
YoY Change -64.91% -79.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -15.26M -25.63M -143.4M
YoY Change -58.75% -32.41%
NET CHANGE
Cash From Operating Activities -8.319M -4.110M -9.140M
Cash From Investing Activities 17.00M 12.10M 128.3M
Cash From Financing Activities -15.26M -25.63M -143.4M
Net Change In Cash -6.578M -17.64M -24.25M
YoY Change -152.82% -905.48%
FREE CASH FLOW
Cash From Operating Activities -$8.319M -$4.110M -$9.140M
Capital Expenditures $686.0K $5.220M $5.950M
Free Cash Flow -$9.005M -$9.330M -$15.09M
YoY Change 76.92% -68.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#DeferredCostsAndOtherAssets
CY2022Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001953366
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Security12b Title
Security12bTitle
Common Shares of Beneficial Interest, $0.001 par value
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
0
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13320000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#DeferredCostsAndOtherAssets
CY2023Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41572
dei Entity Registrant Name
EntityRegistrantName
Star Holdings
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-6762818
dei Entity Address Address Line1
EntityAddressAddressLine1
1114 Avenue of the Americas, 39th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
dei City Area Code
CityAreaCode
212
dei Local Phone Number
LocalPhoneNumber
930-9400
dei Trading Symbol
TradingSymbol
STHO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13319552
CY2023Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
97511000
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
94593000
CY2023Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
20183000
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
18096000
CY2023Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
77328000
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
76497000
CY2023Q2 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
214905000
CY2022Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
232014000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
389000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
925000
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
13400000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
48655000
CY2022Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
37650000
CY2023Q2 us-gaap Other Investments
OtherInvestments
321204000
CY2022Q4 us-gaap Other Investments
OtherInvestments
587138000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54944000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4227000
CY2023Q2 star Accrued Interest And Operating Lease Income Receivable Net
AccruedInterestAndOperatingLeaseIncomeReceivableNet
846000
CY2022Q4 star Accrued Interest And Operating Lease Income Receivable Net
AccruedInterestAndOperatingLeaseIncomeReceivableNet
1132000
CY2023Q2 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
1077000
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
1137000
CY2023Q2 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
18682000
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
16921000
CY2023Q2 us-gaap Assets
Assets
702386000
CY2022Q4 us-gaap Assets
Assets
1005371000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
44304000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
33102000
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
227404000
CY2023Q2 us-gaap Liabilities
Liabilities
271708000
CY2022Q4 us-gaap Liabilities
Liabilities
33102000
CY2022Q4 star Stockholders Equity Net Parent Investment
StockholdersEquityNetParentInvestment
971543000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13320000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
0
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
13000
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
607623000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180761000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
426875000
CY2023Q2 us-gaap Minority Interest
MinorityInterest
3803000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
726000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
430678000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
972269000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
702386000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1005371000
CY2023Q2 us-gaap Management Fee Payable
ManagementFeePayable
7200000
CY2023Q2 us-gaap Revenues
Revenues
25480000
CY2022Q2 us-gaap Revenues
Revenues
40743000
us-gaap Revenues
Revenues
42266000
us-gaap Revenues
Revenues
67614000
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1090000
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1196000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2171000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2411000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7552000
CY2022Q2 star General And Administrative Expense Net Of Adjustments
GeneralAndAdministrativeExpenseNetOfAdjustments
-2067000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21650000
star General And Administrative Expense Net Of Adjustments
GeneralAndAdministrativeExpenseNetOfAdjustments
-1123000
CY2023Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-69000
CY2022Q2 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
22578000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
1632000
us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
22713000
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1750000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1750000
CY2023Q2 us-gaap Other Expenses
OtherExpenses
315000
CY2022Q2 us-gaap Other Expenses
OtherExpenses
41000
us-gaap Other Expenses
OtherExpenses
602000
us-gaap Other Expenses
OtherExpenses
156000
CY2023Q2 us-gaap Costs And Expenses
CostsAndExpenses
38348000
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
70530000
us-gaap Costs And Expenses
CostsAndExpenses
85184000
us-gaap Costs And Expenses
CostsAndExpenses
110544000
CY2023Q2 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-76268000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-166932000
CY2023Q2 star Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-89136000
CY2022Q2 star Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-29787000
star Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-209850000
star Income Loss From Continuing Operations Before Income Loss From Equity Method Investments And Other Items
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestmentsAndOtherItems
-42930000
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1040000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1040000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
242000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8904000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
30216000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21509000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-89934000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-20883000
us-gaap Profit Loss
ProfitLoss
-180674000
us-gaap Profit Loss
ProfitLoss
-21421000
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
27000
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-89961000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-20890000
us-gaap Net Income Loss
NetIncomeLoss
-180676000
us-gaap Net Income Loss
NetIncomeLoss
-21410000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.75
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.75
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.61
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-89934000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-20883000
us-gaap Profit Loss
ProfitLoss
-180674000
us-gaap Profit Loss
ProfitLoss
-21421000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-217000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-5933000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-450000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1610000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-4623000
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
1643000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
-6922000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
2677000
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
250000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-989000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1496000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-89934000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-20633000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-181663000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-22917000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
27000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-11000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-89961000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20640000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-181665000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22906000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
520635000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-89934000
CY2023Q2 star Minority Interest Increase Decrease From Other Changes
MinorityInterestIncreaseDecreaseFromOtherChanges
-23000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
430678000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1301359000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-20883000
CY2022Q2 us-gaap Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease
AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
250000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-8367000
CY2022Q2 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-118903000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1153456000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
972269000
us-gaap Profit Loss
ProfitLoss
-180674000
us-gaap Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease
AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
-989000
us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
3098000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1778000
us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-364781000
star Minority Interest Increase Decrease From Other Changes
MinorityInterestIncreaseDecreaseFromOtherChanges
-23000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
430678000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1224384000
us-gaap Profit Loss
ProfitLoss
-21421000
us-gaap Aoci Including Portion Attributable To Noncontrolling Interest Period Increase Decrease
AociIncludingPortionAttributableToNoncontrollingInterestPeriodIncreaseDecrease
-1496000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-12990000
us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-35021000
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1153456000
us-gaap Profit Loss
ProfitLoss
-180674000
us-gaap Profit Loss
ProfitLoss
-21421000
star Financing Receivable Credit Loss Expense Reversal Including Discontinued Operations
FinancingReceivableCreditLossExpenseReversalIncludingDiscontinuedOperations
1632000
star Financing Receivable Credit Loss Expense Reversal Including Discontinued Operations
FinancingReceivableCreditLossExpenseReversalIncludingDiscontinuedOperations
22713000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1750000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2171000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2411000
us-gaap Share Based Compensation
ShareBasedCompensation
1778000
us-gaap Share Based Compensation
ShareBasedCompensation
-12990000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-484000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-5398000
star Deferred Intereston Loans
DeferredInterestonLoans
4517000
star Deferred Intereston Loans
DeferredInterestonLoans
4738000
star Amortization Of Discounts Or Premiums Deferred Interest And Costs On Lending Investments
AmortizationOfDiscountsOrPremiumsDeferredInterestAndCostsOnLendingInvestments
-215000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
30216000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21509000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
19459000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
8498000
us-gaap Straight Line Rent
StraightLineRent
-60000
us-gaap Straight Line Rent
StraightLineRent
-218000
us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-166932000
star Gain Loss On Extinguishment Of Debt Including Discontinued Operations
GainLossOnExtinguishmentOfDebtIncludingDiscontinuedOperations
-1040000
star Land Development Revenue In Excess Of Cost Of Sales
LandDevelopmentRevenueInExcessOfCostOfSales
-950000
star Land Development Revenue In Excess Of Cost Of Sales
LandDevelopmentRevenueInExcessOfCostOfSales
712000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
292000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
181000
star Increase Decrease In Accrued Interest And Operating Lease And Income Receivable
IncreaseDecreaseInAccruedInterestAndOperatingLeaseAndIncomeReceivable
-756000
star Increase Decrease In Accrued Interest And Operating Lease And Income Receivable
IncreaseDecreaseInAccruedInterestAndOperatingLeaseAndIncomeReceivable
-234000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3452000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1532000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10368000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
537000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4656000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19218000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
2168000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4762000
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
680000
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
355000
star Paymentfor Capital Expenditureson Landand Development Assets
PaymentforCapitalExpendituresonLandandDevelopmentAssets
6761000
star Paymentfor Capital Expenditureson Landand Development Assets
PaymentforCapitalExpendituresonLandandDevelopmentAssets
10088000
star Proceeds From Principal Repayments On Portfolio Of Assets
ProceedsFromPrincipalRepaymentsOnPortfolioOfAssets
31757000
star Proceeds From Principal Repayments On Portfolio Of Assets
ProceedsFromPrincipalRepaymentsOnPortfolioOfAssets
57273000
us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
37650000
us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
49380000
star Proceeds From Sale Of Land And Development Assets
ProceedsFromSaleOfLandAndDevelopmentAssets
21185000
star Proceeds From Sale Of Land And Development Assets
ProceedsFromSaleOfLandAndDevelopmentAssets
38004000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
47165000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1267000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
80372000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-732000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-8985000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
128880000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
59332000
star Proceeds Payments Of Financing Transactions With Istar
ProceedsPaymentsOfFinancingTransactionsWithIstar
-290077000
star Proceeds Payments Of Financing Transactions With Istar
ProceedsPaymentsOfFinancingTransactionsWithIstar
-37921000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
253070000
us-gaap Repayments Of Debt
RepaymentsOfDebt
35000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1262000
us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
635000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-73904000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-37921000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
50320000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
2193000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7474000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17074000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57794000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19267000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54944000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17486000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
2850000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
1781000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57794000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19267000
star Noncash Transactions With Istar Net
NoncashTransactionsWithIstarNet
-74704000
star Noncash Transactions With Istar Net
NoncashTransactionsWithIstarNet
2900000
star Settlement Of Debt Obligations
SettlementOfDebtObligations
115000000
us-gaap Loans Assumed1
LoansAssumed1
125000000
star Capital Expenditures Incurred But Not Yet Paid On Land And Development Assets
CapitalExpendituresIncurredButNotYetPaidOnLandAndDevelopmentAssets
1276000
star Capital Expenditures Incurred But Not Yet Paid On Land And Development Assets
CapitalExpendituresIncurredButNotYetPaidOnLandAndDevelopmentAssets
2789000
CY2023Q1 star Common Stock In Affiliate Received In Spinoff
CommonStockInAffiliateReceivedInSpinoff
13522651
CY2023Q1 star Percentage Of Common Shares Of Beneficial Interest Distributed At Spinoff
PercentageOfCommonSharesOfBeneficialInterestDistributedAtSpinoff
1
CY2023Q1 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q2 star General And Administrative Expense Allocated
GeneralAndAdministrativeExpenseAllocated
-2100000
CY2022Q2 star Interest Expense Allocated
InterestExpenseAllocated
10500000
star General And Administrative Expense Allocated
GeneralAndAdministrativeExpenseAllocated
14100000
star General And Administrative Expense Allocated
GeneralAndAdministrativeExpenseAllocated
-1100000
star Interest Expense Allocated
InterestExpenseAllocated
8000000.0
star Interest Expense Allocated
InterestExpenseAllocated
23800000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1800000
CY2022Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1800000
star Credit Loss Expense Reversal
CreditLossExpenseReversal
23264000
us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Writeoff
DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff
25000000
star Loan Losses For Write Offs
LoanLossesForWriteOffs
25000000
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
1014000
CY2023Q2 us-gaap Financing Receivable Practical Expedient Accrued Interest Exclusion
FinancingReceivablePracticalExpedientAccruedInterestExclusion
true
CY2023Q2 us-gaap Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
5700000
CY2023Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5700000
CY2023Q2 star Tenant Expense Reimbursements
TenantExpenseReimbursements
400000
CY2022Q2 star Tenant Expense Reimbursements
TenantExpenseReimbursements
700000
star Tenant Expense Reimbursements
TenantExpenseReimbursements
800000
star Tenant Expense Reimbursements
TenantExpenseReimbursements
1400000
CY2022Q2 star Allowance For Credit Loss
AllowanceForCreditLoss
3033000
star Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
1600000
star Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
22700000
us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Writeoff
DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff
25000000.0
CY2023Q2 star Financing Receivable Before Allowance For Credit Loss And Other Lending Investments
FinancingReceivableBeforeAllowanceForCreditLossAndOtherLendingInvestments
13789000
CY2022Q4 star Financing Receivable Before Allowance For Credit Loss And Other Lending Investments
FinancingReceivableBeforeAllowanceForCreditLossAndOtherLendingInvestments
49580000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
389000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
925000
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
13400000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
48655000
CY2023Q1 star Allowance For Credit Loss
AllowanceForCreditLoss
458000
CY2023Q2 star Credit Loss Expense Reversal
CreditLossExpenseReversal
-69000
CY2023Q2 star Allowance For Credit Loss
AllowanceForCreditLoss
389000
CY2022Q1 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
2415000
CY2022Q1 star Allowance For Credit Loss
AllowanceForCreditLoss
4932000
CY2022Q2 us-gaap Debt Securities Held To Maturity Credit Loss Expense Reversal
DebtSecuritiesHeldToMaturityCreditLossExpenseReversal
23599000
CY2022Q2 star Credit Loss Expense Reversal
CreditLossExpenseReversal
23101000
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Writeoff
DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff
25000000
CY2022Q2 star Loan Losses For Write Offs
LoanLossesForWriteOffs
25000000
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
1014000
CY2022Q2 star Allowance For Credit Loss
AllowanceForCreditLoss
3033000
CY2023Q1 star Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
-100000
CY2022Q2 star Financing Receivable And Unfunded Commitments Credit Loss Expense Reversal
FinancingReceivableAndUnfundedCommitmentsCreditLossExpenseReversal
-22600000
CY2022Q2 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss Writeoff
DebtSecuritiesHeldToMaturityAllowanceForCreditLossWriteoff
25000000.0
CY2022Q4 star Allowance For Credit Loss
AllowanceForCreditLoss
925000
star Credit Loss Expense Reversal
CreditLossExpenseReversal
-536000
CY2023Q2 star Allowance For Credit Loss
AllowanceForCreditLoss
389000
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
2304000
CY2021Q4 star Allowance For Credit Loss
AllowanceForCreditLoss
4769000
us-gaap Debt Securities Held To Maturity Credit Loss Expense Reversal
DebtSecuritiesHeldToMaturityCreditLossExpenseReversal
23710000
CY2023Q2 star Financing Receivables Allowance For Credit Loss Individually Evaluated For Impairment
FinancingReceivablesAllowanceForCreditLossIndividuallyEvaluatedForImpairment
0
CY2023Q2 star Financing Receivables Allowance For Credit Loss Collectively Evaluated For Impairment
FinancingReceivablesAllowanceForCreditLossCollectivelyEvaluatedForImpairment
389000
CY2023Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
389000
CY2023Q2 star Financing Receivable Net Of Allowance For Credit Losses Individually Evaluated For Impairment
FinancingReceivableNetOfAllowanceForCreditLossesIndividuallyEvaluatedForImpairment
0
CY2023Q2 star Financing Receivable Net Of Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableNetOfAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
13400000
CY2023Q2 us-gaap Notes Receivable Net
NotesReceivableNet
13400000
CY2022Q4 star Financing Receivables Allowance For Credit Loss Individually Evaluated For Impairment
FinancingReceivablesAllowanceForCreditLossIndividuallyEvaluatedForImpairment
396000
CY2022Q4 star Financing Receivables Allowance For Credit Loss Collectively Evaluated For Impairment
FinancingReceivablesAllowanceForCreditLossCollectivelyEvaluatedForImpairment
529000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
925000
CY2022Q4 star Financing Receivable Net Of Allowance For Credit Losses Individually Evaluated For Impairment
FinancingReceivableNetOfAllowanceForCreditLossesIndividuallyEvaluatedForImpairment
29097000
CY2022Q4 star Financing Receivable Net Of Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableNetOfAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
19558000
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
48655000
CY2023Q2 us-gaap Notes Receivable Gross
NotesReceivableGross
13789000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
49580000
CY2023Q2 star Financing Receivable Impaired With Related Allowance Recorded Investment
FinancingReceivableImpairedWithRelatedAllowanceRecordedInvestment
0
CY2023Q2 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
0
CY2023Q2 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
0
CY2022Q4 star Financing Receivable Impaired With Related Allowance Recorded Investment
FinancingReceivableImpairedWithRelatedAllowanceRecordedInvestment
29493000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
29358000
CY2022Q4 us-gaap Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
396000
CY2022Q4 star Number Of Non Accrual Loans
NumberOfNonAccrualLoans
1
star Financing Receivable Impaired With Related Allowance Interest Income Cash Basis Method
FinancingReceivableImpairedWithRelatedAllowanceInterestIncomeCashBasisMethod
0
CY2022Q2 star Financing Receivable Impaired With Related Allowance Interest Income Cash Basis Method
FinancingReceivableImpairedWithRelatedAllowanceInterestIncomeCashBasisMethod
0
star Financing Receivable Impaired With Related Allowance Interest Income Cash Basis Method
FinancingReceivableImpairedWithRelatedAllowanceInterestIncomeCashBasisMethod
0
CY2023Q2 star Financing Receivable Impaired With Related Allowance Interest Income Cash Basis Method
FinancingReceivableImpairedWithRelatedAllowanceInterestIncomeCashBasisMethod
0
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
321204000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
587138000
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
242000
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
8904000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
30216000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
21509000
CY2023Q2 us-gaap Other Assets
OtherAssets
11766000
CY2022Q4 us-gaap Other Assets
OtherAssets
9471000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1604000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1860000
CY2023Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2850000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3247000
CY2023Q2 us-gaap Other Receivables
OtherReceivables
2061000
CY2022Q4 us-gaap Other Receivables
OtherReceivables
1895000
CY2023Q2 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
112000
CY2022Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
129000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
289000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
319000
CY2023Q2 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
18682000
CY2022Q4 us-gaap Deferred Costs And Other Assets
DeferredCostsAndOtherAssets
16921000
CY2023Q2 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
100000
CY2022Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
100000
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100000
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
100000
CY2022Q2 star Amortizationof Above Market Leaseand Lease Incentive Asset
AmortizationofAboveMarketLeaseandLeaseIncentiveAsset
100000
star Amortizationof Above Market Leaseand Lease Incentive Asset
AmortizationofAboveMarketLeaseandLeaseIncentiveAsset
200000
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y2M12D
CY2023Q2 us-gaap Other Liabilities
OtherLiabilities
37147000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
26235000
CY2023Q2 star Accrued Liabilities Other Than Interest
AccruedLiabilitiesOtherThanInterest
5401000
CY2022Q4 star Accrued Liabilities Other Than Interest
AccruedLiabilitiesOtherThanInterest
4861000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1756000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2006000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
44304000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
33102000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21300000
CY2023Q2 us-gaap Management Fee Payable
ManagementFeePayable
7200000
CY2023Q2 star Other Real Estate Payables
OtherRealEstatePayables
5500000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21200000
CY2022Q4 star Other Real Estate Payables
OtherRealEstatePayables
2500000
CY2023Q2 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
600000
us-gaap Interest Costs Capitalized
InterestCostsCapitalized
1000000.0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
243000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
486000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
486000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
486000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
162000
CY2023Q2 star Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1863000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
107000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1756000
CY2023Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.030
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y9M18D
CY2023Q1 star Percentage Of Common Shares Of Beneficial Interest Distributed At Spinoff
PercentageOfCommonSharesOfBeneficialInterestDistributedAtSpinoff
1
CY2023Q1 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
star Number Of Classes Of Common Stock
NumberOfClassesOfCommonStock
1
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13319552
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-89934000
CY2022Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-20883000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-180674000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-21421000
CY2023Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
27000
CY2022Q2 us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
7000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
2000
us-gaap Income Loss From Continuing Operations Attributable To Noncontrolling Entity
IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity
-11000
CY2023Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-89961000
CY2022Q2 us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-20890000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-180676000
us-gaap Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
-21410000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89961000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-89961000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20890000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20890000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-180676000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-180676000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21410000
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-21410000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13320000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13320000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.75
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.75
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.57
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-13.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-13.56
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.61
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.61
CY2022Q2 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2022Q2 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2023Q2 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2023Q2 star Pro Rata Distribution Common Shares Issued For Outstanding Shares At Spinoff
ProRataDistributionCommonSharesIssuedForOutstandingSharesAtSpinoff
0.153
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001558370-23-014241-index-headers.html Edgar Link pending
0001558370-23-014241-index.html Edgar Link pending
0001558370-23-014241.txt Edgar Link pending
0001558370-23-014241-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
stho-20230630.xsd Edgar Link pending
stho-20230630x10q.htm Edgar Link pending
stho-20230630xex31d0.htm Edgar Link pending
stho-20230630xex32d0.htm Edgar Link pending
stho-20230630_def.xml Edgar Link unprocessable
stho-20230630_lab.xml Edgar Link unprocessable
stho-20230630_pre.xml Edgar Link unprocessable
stho-20230630x10q_htm.xml Edgar Link completed
stho-20230630_cal.xml Edgar Link unprocessable